Finerenone – July 2026

  • Brand names:
    • Kerendia®
  • Pharmaceutical Company:
    • BAYER AUSTRALIA LTD
  • Condition/Indication: Heart failure
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026